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Abstract Previously, we showed that Sendai virus fusion pro-
tein (F) acts as an inhibitor of neuraminidase activity of hem-
agglutinin-neuraminidase (HN) protein. Here we report that
synthetic peptides derived from the heptad repeat region prox-
imal to the transmembrane domain (HR2) of Sendai virus F
inhibit fusion and enhance the enzymatic activity of the HN.
This occurs on the virus-bound HN and on its soluble globular
head. The enhancing e¡ect on virus-bound HN is reversible and
depends on the presence of F. The data indicate that, by binding
to the HN ectodomain, the HR2 peptides abolish the F inhibi-
tion of HN and disrupt the communication between the F and
HN essential to promote virus^cell fusion.
( 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Fusion-promoting proteins from several viruses are synthe-
sized as inactive precursors, which are processed by speci¢c
proteases forming two subunits, one involved in the fusion
process, which is activated at the time of the fusion. The
conformational changes needed to activate the fusion proteins
(F) are triggered by di¡erent events, like pH change or recep-
tor binding. It has been suggested that the receptor-binding
subunits act as a clamp to keep the fusion proteins in the
inactive conformation, and that the binding of the receptor
releases the fusion protein which acquires the most stable,
fusion-active conformation [1].
In the paramyxoviruses the mechanism of triggering of the
fusion is poorly understood. Nevertheless it has been shown
that the fusion requires the presence of hemagglutinin-neur-
aminidase (HN), a separate protein carrying the receptor-
binding activity [2], and we have shown [3] that in Sendai
virus, a paramyxovirus, the binding of HN to a soluble re-
ceptor promotes the fusion of the virus with receptor-deprived
cells. Therefore also in paramyxoviruses receptor binding has
a key role in the fusion process, however, it appears that the
trigger for the fusion comes from the interaction between HN
and F, rather than from the dissociation of proteins/subunits
bearing the receptor-binding and fusion-promoting activities.
The fusion-promoting proteins from several unrelated vi-
ruses have two 4-3 heptad repeat (HR) sequences, one near
the N-terminal fusion peptide (HR1), and the other near the
C-terminal transmembrane domain (HR2) [4]. Recent reports
have shown that synthetic peptides, corresponding to the HR2
region, inhibit the fusion process [5^10]. Since in paramyxo-
virus the activation of the fusion requires the interaction be-
tween HN and F, we explored the possibility of an interaction
of the synthetic peptides, containing the HR2 sequence, with
the receptor-binding protein HN. This kind of experiment can
be easily carried out with Sendai virus, where the receptor-
binding activity is located on a protein, HN, which can be
obtained in soluble form (cHN) by selective proteolytic cleav-
age [11]. In the present report we show that inhibitory pep-
tides bind both to cHN and to HN, and that the cHN binding
and fusion inhibition have the same requirements.
2. Materials and methods
2.1. Sendai virus preparation
Sendai virus was grown in the allantoic cavity of 10 day embryo-
nated eggs, and puri¢ed as previously described [12]. The F protein
was inactivated by incubation of the virus with trypsin (2% w/w) for
30 min at 37‡C. Reconstituted Sendai virus envelopes were prepared
from intact and trypsin-inactivated virus as previously described [13].
Liposomes containing HN were prepared from tri£uoperazine-solubi-
lized HN and chloroform/methanol-extracted egg lipids, keeping the
phospholipid/protein ratio similar to that reported for the virus (276
nmol of phospholipid/mg protein [14]).
2.2. HN C-terminal fragment preparation
The water-soluble, C-terminal fragment of HN, cHN, was prepared
with a new procedure. Brie£y, the virus was suspended in 10 mM
MES bu¡er, pH 6.0, containing 150 mM NaCl, and HN was selec-
tively solubilized with tri£uoperazine. The nucleocapsid with the in-
soluble F protein was sedimented by centrifugation at 1000Ug, and
the clear supernatant was treated with trypsin (5% by weight of the
viral proteins) for 20 min at room temperature. The solution was
passed through a column of Amberlite XA2 (9U1.7 cm) to remove
the detergent, and the £ow-through was poured into a phosphocellu-
lose column (9U1.7 cm) equilibrated in 10 mM MES, 150 mM NaCl,
pH 6.0. The unadsorbed material, containing cHN, was concentrated
by centrifugation on Centricon CF25 (Amicon), and appeared as a
single band on SDS^PAGE.
The cHN concentration was determined by the absorbance at 280
nm, with an E1% of 10.83 [15].
2.3. Peptide synthesis
Peptides were synthesized by solid phase methods, using an auto-
mated continuous-£ow peptide synthesizer. The stepwise synthesis was
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carried out by Fmoc/tBu chemistry. The Na-Fmoc amino acids
(4 equiv.) were condensed using DIPCDI (N,N-) (4 equiv.) and
HOBt (1-hydroxybenzotriazole) (4 equiv.) as coupling agents for 1 h
starting to functionalized Wang resin. The peptides were puri¢ed by
high-performance liquid chromatography.
2.4. Enzymatic and hemolytic activities
Enzymatic activity was assayed at 37‡C, using sialyl-lactose as sub-
strate, by measuring the release of sialic acid with the thiobarbituric
acid assay [16].
Hemolytic activity (HE) was detected by incubating, in 20 mM
Tris^HCl, 140 mM NaCl, pH 7.4 (TBS) at 37‡C, viral particles with
2% human red blood cells (type 0, Rh+) obtained from healthy do-
nors who had given informed consent. Samples where then diluted
¢ve-fold with cold TBS, and intact cells were removed by centrifuga-
tion in a bench centrifuge. The released hemoglobin was evaluated as
supernatant absorbance at 413 nm [12]. 100% hemolysis was deter-
mined by addition of Triton X-100, 1% ¢nal concentration, to an
identically treated sample.
2.5. Peptide a⁄nity
The a⁄nity of the peptides for cHN was determined kinetically.
The dependence of the enzymatic activity from the peptide concentra-
tion is:
v
vp3v
¼ 1
K31
1þ Kp½P
 
where v and vp are the reaction rates measured in the absence and in
the presence of the peptide(s), K is the ratio between the catalytic rate
constants in the presence and in the absence of saturating peptide, Kp
is the (kinetically derived) dissociation constant of the peptide from
cHN, and [P] is the concentration of the peptide. When the activation
requires the binding to cHN of n peptide molecules, additional powers
up to (P/Kp)n must be added.
3. Results
3.1. E¡ect of synthetic peptides on Sendai virus hemolytic
activity
It has been previously shown that hemolytic activity of
Sendai virus is inhibited by the peptide 473^495 from the
C-terminal HR region of the F protein [7], and more e⁄cient-
ly by the peptide 465^495, containing one more repeat [17]. In
our experiments we used a 20 amino acid peptide within the
same sequence (residues 473^492, FLQDSKAELEKARKIL-
SEVG). As a control we tested the peptide KKELSLLFGS-
RIVEADKAQE, derived from the same HR2 peptide but
with a scrambled sequence, and a 28 amino acid peptide
derived from the HR2 region of the mumps virus (residues
453^480, TELSKVNASLQNAVKYIRESNHQLQSVS, strain
Glouc1/UK96). Since the peptide is slightly shorter than that
previously described, we ¢rst assayed the e¡ect on the hemo-
lytic activity of Sendai virus. The peptide with the sequence of
the Sendai virus F protein causes 50% inhibition of the hemo-
lytic activity at 17 WM, while both the scrambled peptides and
the heterologous peptide from the F protein of the mumps
virus did not inhibit the hemolytic activity of the Sendai virus.
3.2. E¡ect of the peptide on the enzymatic activity of cHN and
viral native HN
When the same peptides are tested with the soluble form of
the viral neuraminidase, cHN, Sendai virus-derived peptide
causes a remarkable activation of the neuraminidase activity
(NA) at micromolar concentrations, while the scrambled ver-
sion of the same peptide (up to 0.2 mM) and the peptide from
mumps virus (up to 0.3 mM) do not show any e¡ect.
To verify whether peptide acts by modifying the catalytic
activity or by changing the a⁄nity for the substrate, the en-
zymatic activity was measured at di¡erent substrate concen-
trations. The double reciprocal plot shows that peptide does
not modify the Km for the substrate, but only the Vmax (not
shown). This observation indicates that the peptide does not
a¡ect the a⁄nity of HN for the sialic acid-containing recep-
tors, and agrees with the observation that the peptide does not
modify the hemagglutinating activity, as previously reported
for other peptides containing the HR sequence of the F pro-
tein.
The binding a⁄nity of the peptide for cHN was determined
by measuring the extent of activation as a function of the
concentration of the peptide. The plot of the reciprocal of
the relative increase of the neuraminidase activity against
the reciprocal of the peptide concentrations is not linear
(Fig. 1). The best ¢t of the experimental data was obtained
with a third-order polynomial, suggesting that in the activated
state cHN bear three peptide molecules. At least two models,
kinetically indistinguishable, can ¢t the experimental data.
Either the peptide self-associates with a Kass of 1.00U1017
M31, and the trimer binds to cHN with a Kd of 4.69U1037
M, or three peptide molecules independently bind cHN, each
with a Kd of 1.67U1038 M.
The peptide activates not only soluble cHN, but also the
virus-inserted HN. However, the extent of activation of the
enzymatic activity of the virus-inserted HN is dependent on
the presence of the F protein. In the intact virus the peptides
cause about a 100% increase of the enzymatic activity, while
in the trypsin-treated virus, where the F protein is inactivated
by a selective cleavage at arginine 413 [18], the peptides cause
only a 35% increase of the enzymatic activity (Fig. 2A). To
verify whether trypsin treatment modi¢es the response of HN
to the peptide, the activation of the enzymatic activity of HN
in trypsin-treated virus was compared with the activation of
puri¢ed HN inserted into liposomes. In both cases (Fig. 2A)
the extent of activation induced by the peptide is the same,
Fig. 1. E¡ect of the peptide concentrations on cHN activity. The
neuraminidase activity of cHN was assayed in the absence and in
the presence of the peptide, and the reciprocal of the relative in-
crease of the neuraminidase activity is plotted against the reciprocal
of the peptide concentrations.
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meaning that the trypsin modi¢es the response of HN only by
inactivating F.
The description of these experiments changes if we look at
the absolute values of the enzymatic activity, instead of at the
percent activation by the peptide. Since in trypsin-treated vi-
rus the neuraminidase activity is higher than the activity in
untreated virus, a low activation on a more active enzyme and
a high activation on a less active enzyme yield the same enzy-
matic activity (Fig. 2B). The increase of the neuraminidase
activity caused by trypsin destruction of F has already been
observed, and it has been shown that F acts as an allosteric
inhibitor of HN [19]. The data suggest that the peptide has a
dual e¡ect on viral HN: it causes a direct activation of the
enzymatic activity, and suppresses the inhibition generated by
the F protein. Since in the trypsin-treated virus the allosteric
inhibition is already suppressed, the peptide produces only a
lower activation.
3.3. Reversibility of peptide e¡ects
The observation that the HR2 peptide suppresses the inhi-
bition of HN by F suggests that the peptide could inactivate
F. This hypothesis is very likely, in fact the HR2 peptide is
thought to exert its antiviral activity by forming an irrevers-
ible abortive complex with the fusion-promoting proteins.
However, the interaction of HR2 peptides with the fusion
proteins is thought to occur during the irreversible transition
from the non-fusogenic to the fusogenic state. Since under our
experimental conditions there is no evidence of such a tran-
sition, we tested the reversibility of action of the HR2 peptide
on both HN activation and hemolytic activity inhibition.
To verify whether the activation of the neuraminidase ac-
tivity of the viral HN by peptides is reversible, the virus was
incubated with the peptide and then washed two times by
centrifugation. Although the recovery after washing is only
60^70%, both the activation of the neuraminidase activity
and the inhibition of the hemolytic activity appear fully re-
versed by washing (Table 1). The recovery is better evidenced
by the ratio of the activities in peptide-treated and control
virus. This means the peptide does not cause the irreversible
inactivation of the F protein.
4. Discussion
The data reported here clearly indicate that a fusion-inhib-
iting peptide, derived from the HR2 region of the F protein,
reversibly interacts with HN. Moreover, this peptide sup-
presses the already described inhibition of the neuraminidase
activity by F [19]. We have already shown that an allosteric
inhibitory site appears on HN upon binding to the substrate
[20], and that F inhibits the neuraminidase activity of HN,
suggesting that F is the physiological inhibitor of HN [19].
The inhibition of HN appears to correlate with the activation
of F, in fact the binding of a receptor analogue, which dis-
closes the allosteric site, also promotes the fusion of the virus
with receptor-deprived erythrocytes [3].
The binding of the HR2-derived peptide to HN and cHN
suggests that HN^F interactions can occur through the HR2
region of the fusion protein. The binding of HN to the HR2
region of F is consistent with the structure of the F protein
that, although unknown, is reasonably similar to that of F
from Newcastle disease virus. In the three-dimensional struc-
ture of the F protein from Newcastle disease virus [21] the
HR2 is not visible, suggesting that this part of the protein is
poorly structured or, at least, not embedded in a rigid struc-
tural fold. However, an interaction of the HN ectodomain
with the HR2 region of F (very close to the transmembrane
region) requires that the globular head of HN lies close to the
viral membrane. Although this could appear unlikely, it
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Fig. 2. E¡ect of the peptides on the neuraminidase activity of membrane-bound HN. A: Relative increase of the neuraminidase activity induced
by 10 WM peptide. The activity of HN in the absence of peptide is normalized to 100% in each condition (liposomes, virus, trypsin-treated vi-
rus). White bar: HN; gray bar: HN plus peptide. B: Speci¢c activity of HN in untreated and trypsin-treated virus. White bar in the absence
of peptide; gray bar in the presence of peptide.
Table 1
Reversibility of the activation by peptides
Before washing After washing
NA HE NA/HE NA HE NA/HE
Virus 100 100 1.0 65 61 1.06
Virus+peptide 159 72 2.21 67 70 0.96
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should be remembered that early electron microscopy studies
were unable to clearly show spike structures on puri¢ed lipid-
inserted HN [23,24]. In the paper of Hosaka and Shimizu [23],
the virusomes, containing only isolated HN, appeared without
spikes, while Hsu et al. [24] reported electron microscopy
pictures of the reconstituted HN protein showing knob struc-
tures on the lipid surface lacking any kind of stalk. After-
wards, as far as we know, no additional data visualizing the
HN stalk have been reported, and we propose that the HN
ectodomain is connected to the transmembrane domain
through a £exible protein region.
The binding of the HR2 peptide to HN is independent of
the presence of the substrate (or substrate analogue) and ac-
tivates the neuraminidase activity, while activation of F ap-
pears to require the binding of the substrate and the inhibition
of the enzymatic activity. Therefore the binding of HR2-de-
rived peptide evidences a di¡erent interaction between HN
and F.
The interactions between HN and F, and the e¡ects of the
HR2-derived peptide, can be summarized in Fig. 3. The bind-
ing of F to HN through HR2 is likely to occur randomly on
the envelope, keeping part of the HN and F together (Fig.
3A). When the virus binds a receptor on the cell surface, HN
undergoes a conformational change allowing a di¡erent inter-
action with F, resulting in the inhibition of the neuraminidase
activity and in the activation of F. At this point the HR2
region of F could be free to form the six-helix bundle ob-
served in the fusion-active conformation (Fig. 3C).
In light of the above suggested mechanism, the binding of
HR2 peptides to HN, competing with the direct binding of the
HR2 region of F, prevents the correct reciprocal orientation
of HN and F (Fig. 3B), and consequently precludes the inhi-
bition of HN by F (Fig. 3D). In fact, in the virus, the main
contribution to the increase of the neuraminidase activity in-
duced by HR2 peptide comes from suppression of the inhibi-
tion by F.
A quite surprising observation is that the mechanism de-
picted to explain the e¡ect of HR2 peptide on Sendai virus
HN is not con£icting with some recently published experi-
ments on Sendai virus 5, a paramyxovirus which can also
fuse in the absence of HN.
It has been shown that fusion inhibition by HR1 peptides at
low temperatures occurs only when HN is present, and fur-
thermore the extent of fusion in the absence of HN is close to
that observed in the presence of HN and HR1 [22]. If we
suppose that the HR2 region of F is unstructured and func-
tionally binds HN, the HR1 peptides can associate with the
HR2 region and disrupt the HN^F interaction, lowering the
fusion near to the levels observed in the absence of HN. In the
same report it is observed that HR1 peptides decrease the
number of bound red blood cells to the cells expressing the
HN and F from Sendai virus 5. This observation could be
explained by an increase of the neuraminidase activity of HN.
These data agree with the observation that the uncoupling of
HN from F, induced by HR2 peptides, increases the neur-
aminidase activity mainly by suppressing the inhibition by F.
In conclusion, the HR regions of the F protein of para-
myxoviruses appear involved in both the early and late events
of F activation. While the main inhibitory e¡ect of HR pep-
tides appears related to the perturbation of the correct refold-
ing of F from the inactive to the active conformation, HR2
may also be involved in the early triggering of F activation
mediated by the receptor recognition.
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